Magnolia Eye Group is offering the Valeda Light Delivery System as a treatment option for people diagnosed with dry age-related macular degeneration, according to a post published by the Hernando Main Street Chamber of Commerce.
The post describes the treatment as non-invasive and says it does not involve injections. It also states that Valeda is FDA-authorized for dry AMD and is available to select patients with dry macular degeneration.
The Chamber post says the treatment may help improve vision and preserve quality of life for eligible patients. It encourages people to call Magnolia Eye Group to schedule a consultation to determine whether they meet the requirements.
